Table 9.
Shared criteria | Unique criteria | Altered criteria | |||||
---|---|---|---|---|---|---|---|
AVCG names | PP2 | PP4 | PP1 | PP3 | |||
Variant | ACMG names | PP2 | PP4 | PM2 | PP3 | Label | |
CYP11B1:g.84247412G > A (congenital adrenal hyperplasia) | AVCG | NA | VUS | ||||
ACMG | NA | VUS | |||||
L2HGDH:g.100207200 T > C (L-2-hydroxyglutaric aciduria) | AVCG | NA | VUS | ||||
ACMG | NA | VUS | |||||
MTM1:g.125938001C > T (Myotubular myopathy 1) | AVCG | NA | VUS | ||||
ACMG | NA | VUS | |||||
NPC1:g.48250290 T > G (Niemann-Pick disease type C1) | AVCG | NA | VUS | ||||
ACMG | NA | VUS |
Underneath each variant, the associated phenotype is mentioned. Only the criteria that were fulfilled, are presented. A green label implies support for a pathogenic classification and is thus considered a positive or correct effect. The criteria are divided in three groups: the ones which remained identical for ACMG and AVCG (“shared” criteria), the ones which are present in only one of those two sets of guidelines (“unique” criteria) and the ones which have been altered to make the AVCG (“altered” criteria). The full criterion corresponding with the names can be found in Table 4. For every variant, there are not enough supporting, moderate and/or strong criteria fulfilled to be classified as likely pathogenic. ACMG, American College of Medical Genetics and Genomics; AVCG, Animal Variant Classification Guidelines; VUS, variant of uncertain significance; NA, not applicable.